Literature DB >> 8671499

High incidence of triploidy in in-vitro fertilized oocytes from a patient with a previous history of recurrent gestational trophoblastic disease.

L Pal1, T L Toth, L Leykin, K B Isaacson.   

Abstract

The patient described has a history of recurrent gestational trophoblastic disease following spontaneous conception. She subsequently underwent two cycles of in-vitro fertilization (IVF) for management of infertility related to tubal obstruction. IVF of the oocytes retrieved showed a significantly high incidence of abnormal fertilization resulting in the development of triploid embryos. This report explores the possible association of an oocyte defect predisposing to abnormal fertilization, resulting in a high incidence of triploid embryos. Since the development of partial hydatidiform moles is related to the origin of triploidy, this phenomenon is suggested to explain the occurrence of recurrent trophoblastic disease in this patient. We propose the use of intracytoplasmic sperm injection (ICSI) as a therapeutic option to minimize the incidence of triploidy in future IVF cycles; donor oocyte IVF would be another alternative.

Entities:  

Mesh:

Year:  1996        PMID: 8671499     DOI: 10.1093/oxfordjournals.humrep.a019432

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

1.  Complete hydatidiform mole and normal live birth following intracytoplasmic sperm injection.

Authors:  Haruka Hamanoue; Nobuko Umezu; Mika Okuda; Naoki Harada; Takako Ohata; Haruya Sakai; Takeshi Mizuguchi; Hiroshi Ishikawa; Tsuneo Takahashi; Kiyonori Miura; Fumiki Hirahara; Naomichi Matsumoto
Journal:  J Hum Genet       Date:  2006-03-17       Impact factor: 3.172

2.  Live euploid birth and complete hydatid mole, followed by partial hydatid mole after ICSI.

Authors:  Ming-Tzeung Chung; Chii-Ruey Tzeng; Ching-Hui Chen; Cindy Chan; Yi-En Chang; Yi-Hua Wu; Chi-Huang Chen
Journal:  J Assist Reprod Genet       Date:  2018-06-02       Impact factor: 3.412

3.  No evidence for mutations in NLRP7 and KHDC3L in women with androgenetic hydatidiform moles.

Authors:  Sangeetha Mahadevan; Shu Wen; Alfred Balasa; Gary Fruhman; Julio Mateus; Andrew Wagner; Tarek Al-Hussaini; Ignatia B Van den Veyver
Journal:  Prenat Diagn       Date:  2013-10-04       Impact factor: 3.050

4.  Application of next-generation sequencing to preimplantation genetic testing for recurrent hydatidiform mole patients.

Authors:  Jingyi Yang; Zhiqiang Yan; Yan Liu; Xiaohui Zhu; Rong Li; Ping Liu; Liying Yan; Jie Qiao; Xu Zhi
Journal:  J Assist Reprod Genet       Date:  2021-10-04       Impact factor: 3.412

5.  Reproductive Outcomes from Maternal Loss of Nlrp2 Are Not Improved by IVF or Embryo Transfer Consistent with Oocyte-Specific Defect.

Authors:  Sara Arian; Jessica Rubin; Imen Chakchouk; Momal Sharif; Sangeetha K Mahadevan; Hadi Erfani; Katharine Shelly; Lan Liao; Isabel Lorenzo; Rajesh Ramakrishnan; Ignatia B Van den Veyver
Journal:  Reprod Sci       Date:  2020-10-22       Impact factor: 2.924

6.  Association between gestational trophoblastic disease (GTD) history and clinical outcomes in in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles.

Authors:  Xinyu Cai; Mei Zhang; Chenyang Huang; Yue Jiang; Jidong Zhou; Manlin Xu; Guijun Yan; Haixiang Sun; Na Kong
Journal:  Reprod Biol Endocrinol       Date:  2022-02-04       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.